VIVO - Meridian Bioscience Inc.
Close
33.97
0 0%
Share volume: 0
Last Updated: Mon 30 Jan 2023 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$33.97
0.00
0.00%
View ratios
Fiscal Date | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
Report Date | 2022-02-04 | 2022-05-06 | 2022-08-05 | 2022-11-22 | |
Total revenue | 88.341 M | 111.231 M | 67.771 M | 65.675 M | |
Cost of revenue | 39.182 M | 42.754 M | 31.043 M | 31.683 M | |
Gross profit | 49.159 M | 68.477 M | 36.728 M | 33.992 M | |
39.30% | -46.36% | -7.45% | |||
Operating expenses | 28.595 M | 31.760 M | 27.370 M | 25.031 M | |
Selling general and admin | 22.401 M | 26.069 M | 21.327 M | 18.624 M | |
Research and development | 6.194 M | 5.691 M | 6.043 M | 6.407 M | |
Total expenses | 67.777 M | 74.514 M | 58.413 M | 56.714 M | |
9.94% | -21.61% | -2.91% | |||
Operating income | 20.564 M | 36.717 M | 9.358 M | 8.961 M | |
Ebit | 20.564 M | 36.717 M | 9.358 M | 8.961 M | |
Pretax income | 19.751 M | 36.535 M | -6.602 M | 4.633 M | |
84.98% | -118.07% | -170.18% | |||
Income tax | 4.411 M | 7.783 M | 736.000 K | -1.072 M | |
Net income basic | 15.340 M | 28.752 M | -7.338 M | 5.705 M | |
87.43% | -125.52% | 177.75% | |||
Net income | 15.340 M | 28.752 M | -7.338 M | 5.705 M | |
87.43% | -125.52% | 177.75% |